Aurinia Pharmaceuticals is a startup based in Canada.
Based in Canada, Aurinia Pharmaceuticals is a startup.
Aurinia Pharmaceuticals has developed the first oral therapy for lupus nephritis, a condition that causes irreversible kidney damage and increases the risk of kidney failure, cardiac events, and death.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.